The Freshfields Podcast
By Freshfields Bruckhaus Deringer
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Freshfields Bruckhaus Deringer
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 14
Reviews: 0
Episodes: 110
Description
We are a global law firm with a long-standing track record of successfully supporting the world’s leading national and multinational corporations, financial institutions and governments on ground-breaking and business-critical mandates.
| Episode | Date |
|---|---|
|
Reward(ing) Half Hour: Episode 2 Remuneration vs Compensation – the Transatlantic Pay Debate
|
May 08, 2024 |
|
No Worse Off #4: Richard Tett, 30 years in restructuring
|
May 02, 2024 |
|
Essential Antitrust #39: UK in-depth merger reviews: new process adopted by the CMA
|
Apr 29, 2024 |
|
No Worse Off #3: UK Restructuring Plans – Relevant Alternative, timetabling and jurisdiction
|
Apr 15, 2024 |
|
No Worse Off #2: After the battles, a coming of age for the UK restructuring plan?
|
Apr 04, 2024 |
|
Reward(ing) Half Hour: Being prepared for the (not so) unexpected: planning for executive exits
|
Mar 25, 2024 |
|
Tax Matters: Spring Budget 2024 – The Hunt for Blue October
|
Mar 07, 2024 |
|
No Worse Off #1: Overview of current restructuring trends
|
Mar 05, 2024 |
|
Essential Antitrust #38: What businesses can expect from China’s revised merger control regime
|
Feb 08, 2024 |
|
Impressions from the J.P. Morgan Healthcare Conference – A MedTech Perspective
|
Feb 01, 2024 |
|
Essential Antitrust #37: Antitrust in 2024: competition enforcement takes center stage
|
Jan 18, 2024 |
|
Legends of Tech #1: Turing with Vint and Whit: Boris Feldman in conversation with Vinton G. Cerf and Whitfield Diffie
|
Jan 12, 2024 |
|
Essential Antitrust Asia #9: updates with ABNR on antitrust in Indonesia
|
Jan 10, 2024 |
|
Managing Risk in Asia #8: Opportunities for Asian and US investors post-US Executive Order on outbound investments
|
Dec 28, 2023 |
|
Tax Matters: Trends in tax disputes – what should businesses be aware of?
|
Dec 13, 2023 |
|
Essential Antitrust #36: The UK’s Digital Markets, Competition and Consumers Bill – what you need to know
|
Dec 08, 2023 |
|
Essential Antitrust #35: Gender Inclusive Antitrust Toolkit: a new lens for policy and enforcement
|
Nov 29, 2023 |
|
Tax Matters: Autumn Statement 2023 – tax cuts in the NIC of time?
|
Nov 23, 2023 |
|
How secondaries have become primary to GPs and LPs
|
Nov 17, 2023 |
|
From chaos to control: making the case for legal project managers
|
Nov 16, 2023 |
|
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
|
Oct 18, 2023 |
|
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
|
Sep 18, 2023 |
|
MedTech Across Borders – Recent Developments in Japan and the US
|
Sep 06, 2023 |
|
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
|
Aug 01, 2023 |
|
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
|
Jul 26, 2023 |
|
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
|
Jul 24, 2023 |
|
Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech
|
Jul 20, 2023 |
|
Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?
|
Jun 08, 2023 |
|
Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals
|
May 25, 2023 |
|
Global Perspectives on Health Data Offerings and Considerations for Innovators
|
May 04, 2023 |
|
Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero
|
Apr 18, 2023 |
|
Essential Antitrust #27: Some Key Takeaways from the Enforcers Roundtable at the 2023 ABA Antitrust Spring Meeting
|
Apr 04, 2023 |
|
MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan
|
Mar 28, 2023 |
|
Episode #1: The EU’s Corporate Sustainability Due Diligence Directive– a turning point for business
|
Mar 22, 2023 |
|
Essential Antitrust Asia #8: Hot topics in China antitrust
|
Mar 17, 2023 |
|
Tax Matters: Ready, Steady, Growth – Business tax implications of the UK Spring Budget 2023
|
Mar 16, 2023 |
|
Essential Antitrust #26: Foreign subsidy control: EU gears up to review deals and business conduct
|
Feb 20, 2023 |
|
Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools
|
Jan 25, 2023 |
|
MedTech - A Conversation with Stacy Hostetler
|
Dec 15, 2022 |
|
Essential Antitrust #24: Cartel enforcement is back: dawn raids in Europe and new targets in the US
|
Dec 12, 2022 |
|
MedTech - A Conversation with Gloria Seibert
|
Dec 01, 2022 |
|
Tax Matters podcast: How will the UK Autumn Statement 2022 affect your business?
|
Nov 18, 2022 |
|
Essential Antitrust #23: Merger challenges in US courts: deciphering US antitrust agencies’ recent string of defeats
|
Oct 26, 2022 |
|
Great (stakeholder) expectations: Episode 4 - Activists all around
|
Oct 20, 2022 |
|
Great (stakeholder) expectations: Episode 3 - A bastion of support for social issues
|
Oct 18, 2022 |
|
Great (stakeholder) expectations: Episode 2 - Unpacking the status of climate disclosures
|
Oct 13, 2022 |
|
State of play on Pillar Two
|
Oct 12, 2022 |
|
Great (stakeholder) expectations: Episode 1 - A turning point for ESG
|
Oct 11, 2022 |
|
Essential Antitrust Asia #7: Key antitrust issues in Japan
|
Sep 22, 2022 |
|
Managing Risk in Asia #6: Managing transactional risks in life science investments in Asia
|
Aug 23, 2022 |
|
Tax matters: what is the impact of the proposed restrictions to the UK sovereign immunity tax exemption?
|
Aug 10, 2022 |
|
A new European AML authority – A year on
|
Jul 20, 2022 |
|
MedTech and Health Equity for Women - A Conversation with Marissa Fayer
|
Jun 28, 2022 |
|
Essential Antitrust #22: Global focus on labor: not necessarily business as usual
|
Jun 22, 2022 |
|
Does the proposed UK corporate re-domiciliation regime measure up?
|
Jun 09, 2022 |
|
Essential Antitrust #21: New EU and UK distribution rules for the next decade: check for compliance and new opportunities
|
May 31, 2022 |
|
Essential Foreign Investment #4: Expanding areas of global regulation
|
May 19, 2022 |
|
Essential Antitrust Asia #6: Key updates and enforcement trends in Hong Kong
|
May 05, 2022 |
|
Fintech in focus: Buy now, pay later
|
May 03, 2022 |
|
Navigating risks: tax disputes and privilege
|
Apr 08, 2022 |
|
Future trends in MedTech
|
Apr 01, 2022 |
|
Essential Antitrust #20: Innovation-driven deals: plan for success (part 2)
|
Mar 30, 2022 |
|
Essential Antitrust #19: Innovation-driven deals: plan for success (part 1)
|
Mar 24, 2022 |
|
UAE employee monitoring and compliance #3: strategies and best practice to combat cyberattacks, mitigate and manage risks
|
Mar 16, 2022 |
|
Essential Antitrust #18: US review of merger guidelines: what could it mean for M&A?
|
Feb 21, 2022 |
|
Investing in tech: trends to watch in the year ahead
|
Feb 09, 2022 |
|
Managing risk in Asia #5: Investment strategy risk in a dynamic region
|
Jan 25, 2022 |
|
UK financial services enforcement in 2021 – Themes and a landmark
|
Jan 24, 2022 |
|
Essential Antitrust #17: Antitrust in 2022: 10 key themes - is your business ready for rapid change?
|
Jan 20, 2022 |
|
Tax matters: German election – what does the new coalition mean to business?
|
Dec 23, 2021 |
|
Investing in tech: regulation to disrupt tech deal-making?
|
Dec 22, 2021 |
|
The Big Conversation podcast: Future risks
|
Dec 21, 2021 |
|
Spotlight on Africa - The Evolution of our Africa Practice
|
Dec 15, 2021 |
|
Buyer beware: avoiding privacy and cyber hazards in M&A
|
Dec 14, 2021 |
|
The Big Conversation podcast: the transition to net zero
|
Dec 10, 2021 |
|
Fintech in focus: why governance matters
|
Dec 09, 2021 |
|
Essential Foreign Investment #3: Developments in the US and China
|
Dec 08, 2021 |
|
Tax matters: Digital taxes and trade wars – will the OECD/G20 agreement bring tax peace?
|
Nov 29, 2021 |
|
Essential Antitrust Asia #5: Update with Gilbert + Tobin on proposals to reform Australia’s merger regime
|
Nov 26, 2021 |
|
What does BT 21, the EU’s ‘business taxation for the 21st century’ package, mean for US business?
|
Nov 11, 2021 |
|
From growth to maturity: what founders and investors need to know about going public
|
Oct 29, 2021 |
|
Essential Antitrust #16: Global merger control: the EU and UK take centre stage
|
Oct 28, 2021 |
|
The keys to successful corporate venture capital investing
|
Oct 26, 2021 |
|
Tax matters: German election – what do the coalition developments mean for global and domestic tax policy?
|
Oct 25, 2021 |
|
View from the Valley #7: The future of data privacy in the United States
|
Oct 11, 2021 |
|
Essential Antitrust #15: Focus on fintech deals: navigating a tougher regulatory environment
|
Sep 30, 2021 |
|
Essential Antitrust Asia #4: India update with AZB & Partners
|
Sep 23, 2021 |
|
Arbitration Money Matters: The Economics of an Arbitration
|
Sep 09, 2021 |
|
Arbitration Insider – International arbitration: pathway to success
|
Sep 08, 2021 |
|
The rise of the individual in financial markets – developments and impact for firms
|
Aug 23, 2021 |
|
Tax matters: Navigating the EU's "Business Taxation for the 21st century" package
|
Aug 17, 2021 |
|
European AML legislative package - An overview
|
Aug 06, 2021 |
|
Essential Foreign Investment #2: The road to tougher FDI screening?
|
Aug 05, 2021 |
|
Managing risk in Asia #4: what is driving ESG risks across the region?
|
Aug 04, 2021 |
|
Essential Antitrust #14: President Biden’s Executive Order on promoting competition: a progressive agenda with a focus on labor-related issues
|
Jul 26, 2021 |
|
View from the Valley #6: Should US tech companies be worried about Russia?
|
Jul 16, 2021 |
|
Fintech in focus: paying cross-border
|
Jul 12, 2021 |
|
Tax matters: what UK tax disclosure plan means for business
|
Jul 07, 2021 |
|
Arbitration Insider: What disputes can we expect in 2021?
|
Jun 30, 2021 |
|
Essential Antitrust #13: Financing green transition: how will the EU support industry?
|
Jun 29, 2021 |
|
FS market conduct #4: a look at insider dealing and trading on inside information
|
Jun 17, 2021 |
|
Rethinking the supply chain #2: renegotiating long-term contracts
|
Jun 17, 2021 |
|
Managing risk in Asia #3: the value of a diverse board
|
Jun 16, 2021 |
|
UAE employee monitoring and compliance #2: whistleblowing
|
Jun 10, 2021 |
|
Arbitration Insider: Why is climate change and arbitration such a hot topic?
|
Jun 02, 2021 |
|
Essential Antitrust Asia #3: Merger control in Vietnam
|
May 30, 2021 |
|
Essential Antitrust #12: Merger control: are we witnessing a paradigm shift?
|
May 26, 2021 |
|
Ransomware: what boards need to know about the Colonial Pipeline attack
|
May 19, 2021 |
|
The EU’s AI Regulation #1: Understanding the draft rules
|
May 06, 2021 |
|
Essential Foreign Investment #1: CFIUS, China and Europe’s new screening regime
|
Apr 26, 2021 |